Listed by the USPTO as COBANOGLU, DILEK B
Tech Center 3600 • Art Units: 3626 3627 3683 3686 3687
This examiner grants 33% of resolved cases
COBANOGLU, DILEK B is a USPTO patent examiner in tech center 3600 and art unit 3626. The record covers 506 resolved cases, with an allowance rate of 33.2%, a median of 1607 days to allowance, and a 27.3% interview lift. The allowance figure and pendency figure indicate that applications may require sustained prosecution attention, while the interview result supports considering direct engagement.
The listed companies are Cerner Innovation Inc., Biotronik SE & Co. KG, and KPN Innovations LLC. The listed firms are Invoke, CALDWELL LLC, and ALG Intellectual Property | IQVIA. These names identify representative experience in healthcare, communications, and related technology matters for practitioners evaluating prosecution strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19040945 | ENVIRONMENTAL INFORMATION COLLECTION DEVICE, ENVIRONMENTAL INFORMATION COLLECTION METHOD, AND RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 17613774 | METHODS AND APPARATUS FOR GENERATING A GRAPHICAL REPRESENTATION | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18698097 | AUTOMATIC RADIOTHERAPY PRESCRIPTION ANOMALY DETECTION | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 19474449 | Peripheral artery disease step counter | Non-Final OA | BIOTRONIK SE & Co. KG |
| 18714365 | METHOD FOR CLASSIFYING A MEDICAL DEVICE AND/OR DRUG, SYSTEM AND TRAINING METHOD | Non-Final OA | BIOTRONIK AG |
| 19364650 | SYSTEMS AND METHODS FOR PROCESSING PROFILES INCLUDED IN A PROTECTED DATASET MAINTAINED IN A SECURED NETWORK LOCATION TO DETERMINE CORRELATIONS BETWEEN INDICATORS REPRESENTING LATENT PATTERNS THAT ARE INDICATIVE OF A CONDITION | Non-Final OA | AML JV, LLC |
| 18863098 | INTEGRATED THERAPY CHAIN | Final Rejection | Aesculap AG |
| 18910185 | SYSTEMS AND METHODS FOR MEDICAL CLAIMS ANALYTICS AND PROCESSING SUPPORT | Final Rejection | ZOLL Medical Corporation |
| 18439997 | MEDICAL DEVICE FOR ESTIMATING RISK OF PATIENT DETERIORATION | Non-Final OA | ZOLL Medical Corporation |
| 19026206 | Integrated Coordination Of Care | Final Rejection | Cerner Innovation, Inc. |
| 19026246 | Integrated Coordination Of Care | Final Rejection | Cerner Innovation, Inc. |
| 19026234 | Integrated Coordination Of Care | Final Rejection | Cerner Innovation, Inc. |
| 18767726 | Integrated Coordination Of Care | Non-Final OA | Cerner Innovation, Inc. |
| 17150372 | INTELLIGENT SITUATIONAL ALARMS AND NOTIFICATIONS FOR DIABETES MANAGEMENT DEVICES | Non-Final OA | Insulet Corporation |
| 18235510 | METHOD FOR PREDICTING RISK OF DEPRESSION RELAPSE OR ONSET | Non-Final OA | IQVIA Inc. |
| 18128592 | AI BASED SYSTEMS AND METHODS FOR PROVIDING A CARE PLAN | Non-Final OA | CVS Pharmacy, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy33.2% of resolved applications examined by Dilek B Cobanoglu were allowed (506 resolved cases), compared with 24.6% across Art Unit 3626 over the last five years.
This examiner's interview lift is +27.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Dilek B Cobanoglu took 1,607 days on average from filing to allowance.
Dilek B Cobanoglu examines applications in Art Unit 3626 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).
